Category: Cross-Border and International

Jet-Themed Crystal Deal Toy

Crystal deal toy commemorating the acquisition by Japanese manufacturer Mitsubishi of the Canadair regional jet program of Canadian firm Bombardier.

(20AJH062)
2 Images
Custom crystal deal toy marking the sale to Mitsubishi of Canadair, Bombardier's regional jet program.

Custom Crystal for Series A Funding

Custom crystal celebrating Series A for Copenhagen-based podcast provider Podimo.

(20LJW11)
1 Image

Flag-Themed Pharmaceutical Deal Toy

Custom crystal deal toy commemorating the acquisition of Canada’s Dalton Pharma Services by Japanese pharmaceutical firm Seikagaku Corporation.

(20AMF085)
2 Images
Crystal deal toy marking a cross-border acquisition of Canadian Dalton Pharma Services. The acquirer was Seikagaku Corporation, an R&D-centered Japanese pharmaceutical firm.

Flying Taxi-Themed Deal Tombstone

Crystal deal tombstone marking an investment by Japanese auto manufacturer Toyota in California-based Joby Aviation. Joby has developed a piloted, five-seat flying vehicle.

(20AJH011)
1 Image

Medical Clinic Deal Toy

Crystal deal toy commemorating the acquisition of CentroMedico Santagostino, a network of medical clinics based in Italy.

(20LSS044)
2 Images
Back view of crystal financial tombstone marking the acquisition of CentroMedico Santagostino, an Italian network of health care centers.

Crystal Commemorative for Fund Closing

Custom crystal commemorating the closing of Creador IV, a fund focused on investment in Malaysia, Singapore, Indonesia, and India,

(20AMF007)
2 Images
Crystal deal toy, incorporating a world map, celebrating the closing of the Creador IV fund, based in Kuala Lumpur.

Beach-Themed Deal Tombstone

Custom crystal deal tombstone marking the takeover of Echo Resources, which operates the Yandal Gold Project in Western Australia.

(20AKL073)
1 Image

Lung-Themed Crystal Deal Toy

Crystal deal toy, featuring a 3D laser-etch of lungs, commemorating a drug commercialization agreement in Japan. The collaboaration between biotherapeutics firm aTyr Pharma and Kyorin Pharmaceutical centers on a treatment for lung diseases.

(20ALJ110)
1 Image